A Study of SC Administration of Trastuzumab (Herceptin) by SID at Home in HER2-Positive EBC Participants

NCT02040935 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

128

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Trastuzumab

Sponsor

Hoffmann-La Roche